NCT00091832 Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00089791 A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis Status COMPLETED Phase PHASE3
NCT00043186 Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density Status COMPLETED Phase PHASE2